What does Aarti Pharma do?
Aarti Pharmalabs Ltd manufactures Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, and New Chemical Entities (NCE) in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of ₹5,638 Cr and a net profit of ₹883 Cr, with a market cap of ₹8,574 Cr.
Overview: Aarti Pharmalabs Ltd is engaged in the manufacture of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives, operating within the Pharmaceuticals & Biotechnology industry as a Mid Cap company.History:
Aarti Pharmalabs Ltd was incorporated as a Public Limited Company in 2019 and changed its name from Aarti Organics Limited to Aarti Pharmachem Limited on July 1, 2021. The most recent quarterly results reported net sales and profit for the period ending March 2025.
Financial Snapshot:
Net Sales: 5,638 Cr (Quarterly Results - Mar 2025)
Net Profit: 883 Cr (Quarterly Results - Mar 2025)
Market Cap: INR 8,574 Cr (Mid Cap)
Key Metrics:
P/E: 32.00
Industry P/E: 37
Dividend Yield: 0.37%
Debt-Equity: 0.18
Return on Equity: 13.69%
Price to Book: 4.31
Contact Details:
Details: No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
